tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

MIRO Stock Latest News

Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results
Press ReleasesMiromatrix to Report Fourth Quarter and Full Year 2022 Financial Results
8d ago
MIRO
MIRO Tanks after Public Offering
Market NewsMIRO Tanks after Public Offering
15d ago
MIRO
Miromatrix Medical 6.25M share Spot Secondary priced at $1.60
The FlyMiromatrix Medical 6.25M share Spot Secondary priced at $1.60
15d ago
MIRO
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
Press ReleasesMiromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
16d ago
MIRO
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
Press ReleasesMiromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
16d ago
MIRO
Miromatrix Medical announces common stock offering, no amount given
The FlyMiromatrix Medical announces common stock offering, no amount given
16d ago
MIRO
Miromatrix MiroliverELAP timeline pushed out two or three quarters, says Piper
The FlyMiromatrix MiroliverELAP timeline pushed out two or three quarters, says Piper
2M ago
BAX
MIRO
Miromatrix Medical, Baxter enter research agreement for ALF
The FlyMiromatrix Medical, Baxter enter research agreement for ALF
2M ago
BAX
MIRO
Miromatrix Medical, Baxter announce collaborative ALF research agreement
The FlyMiromatrix Medical, Baxter announce collaborative ALF research agreement
2M ago
BAX
MIRO
Miromatrix Medical to submit response to clinical hold letter in 2H23
The FlyMiromatrix Medical to submit response to clinical hold letter in 2H23
2M ago
MIRO
Miromatrix Plunges After  Clinical Hold
Market NewsMiromatrix Plunges After Clinical Hold
3M ago
MIRO
Miromatrix Medical announces FDA clinical hold on miroliverELAP IND application
The FlyMiromatrix Medical announces FDA clinical hold on miroliverELAP IND application
3M ago
MIRO
Miromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP
Press ReleasesMiromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP
3M ago
MIRO
Miromatrix Announces Participation in the Piper Sandler 34th Annual Healthcare Conference
Press ReleasesMiromatrix Announces Participation in the Piper Sandler 34th Annual Healthcare Conference
4M ago
MIRO
Miromatrix Medical price target raised to $9 from $8 at Piper Sandler
The FlyMiromatrix Medical price target raised to $9 from $8 at Piper Sandler
4M ago
MIRO
Miromatrix Medical reports Q3 EPS (37c), two estimates (40c)
The FlyMiromatrix Medical reports Q3 EPS (37c), two estimates (40c)
4M ago
MIRO
Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update
Press ReleasesMiromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update
4M ago
MIRO
Miromatrix CEO Jeff Ross Delivering Keynote Address at ARMI | BioFabUSA 2022 Fall Summit: Meeting in the Millyard
Press ReleasesMiromatrix CEO Jeff Ross Delivering Keynote Address at ARMI | BioFabUSA 2022 Fall Summit: Meeting in the Millyard
5M ago
MIRO
Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa
Press ReleasesMiromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa
6M ago
MIRO
Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
Press ReleasesMiromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
6M ago
MIRO
Miromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase
Press ReleasesMiromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase
7M ago
MIRO
Miromatrix Appoints Jack Lake, M.D., as Medical Director
Press ReleasesMiromatrix Appoints Jack Lake, M.D., as Medical Director
8M ago
MIRO
Miromatrix Announces Participation in the 19th Annual Craig-Hallum Institutional Investor Conference
Press ReleasesMiromatrix Announces Participation in the 19th Annual Craig-Hallum Institutional Investor Conference
10M ago
MIRO
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.